Elevations of Cardiac Troponin‐I Quantified with the Erenna® cTnI Immunoassay are an Early Indicator of Heart Muscle Injury in Studies of Cardiotoxicity

29 Mar 2012

This application note describes the utility of the Erenna Immunoassay System and the Erenna cTnI Assay towards early assessment of cardiotoxicity in rats. Due to its unique high definition technology it is shown that elevated levels of cTnI in serum can be detected earlier with the Erenna Immunoassay System.

Links

Tags

ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.CardiotoxicityHeart Muscle InjuryHeart Muscle InjuryCardiotoxicity
Elevations of Cardiac Troponin‐I Quantified with the Erenna® cTnI Immunoassay are an Early Indicator of Heart Muscle Injury in Studies of Cardiotoxicity